Original Research
Published on 25 Mar 2021
TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2021.649135
- 7,624 views
- 13 citations
